ARS Pharma to Present Real-World Data on Intranasal Epinephrine at 2025 American College of Allergy, Asthma & Immunology Annual Scientific Meeting Life Science Investing
Biogen to Highlight Scientific Progress in Rare Kidney Disease at American Society of Nephrology Kidney Week 2025 Life Science Investing
Benitec Biopharma Provides Positive Interim Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial and Receives FDA Fast Track Designation for BB-301 Life Science Investing
Britannia Life Sciences Inc. Enters into $11.3 Million Share Exchange Agreement with McEwen Inc. and Britannia Mining Solutions Inc. Life Science Investing
Axsome Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update Life Science Investing
Benitec Biopharma Announces Appointment of Sharon Mates Ph.D. to its Board of Directors Life Science Investing
Tenax Therapeutics to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference Life Science Investing
TScan Therapeutics Reaches Agreement with FDA on Pivotal Study Design for TSC-101 and Announces Strategic Prioritization to Advance TSC-101 and Extend Cash Runway into H2 2027 Life Science Investing
Benitec Biopharma to Provide Phase 1b/2a Clinical Study Update for BB-301 in Oculopharyngeal Muscular Dystrophy Life Science Investing
